Article
Specific protection against breast cancers by cyclin D1 ablation.
Nature - 28 Jun 2001
Yu Q, Geng Y, Sicinski P
Abstract excerpt
Breast cancer is the most common malignancy among women. Most of these cancers overexpress cyclin D1, a component of the core cell-cycle machinery. We previously generated mice lacking cyclin D1 using gene targeting. Here we report that these cyclin D1-deficient mice are resistant to breast cance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.